在评估甲状腺相关轨道病变的内镜轨道减压的新型指标
Jieliang Shi1, Zhaoqi Pan1, Yunhai Tu1
1Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Frontiers in endocrinology
|April 23, 2025
概括
有效轨道体积 (IREOV) 的增长率有效地衡量了甲状腺相关轨道病变 (TAO) 手术后的结果. 介面壁解压显示IREOV高于侧面壁解压,特别是在肌肉缩病例中.
科学领域:
- 眼科医生 眼科 眼科
- 医疗成像医学成像
- 人工智能的人工智能
背景情况:
- 甲状腺相关的轨道病变 (TAO) 通常需要手术干预,如内镜轨道减压.
- 评估手术结果,特别是缩和轨道体积变化,对于患者管理至关重要.
- 需要新的指标来准确评估不同压缩减压技术的有效性.
研究的目的:
- 引入有效轨道体积增长率 (IREOV) 作为评估TAO内镜轨道减压的新度量.
- 为了比较使用IREOV的中间壁解压缩 (MWD) 与侧壁解压缩 (LWD) 的有效性.
- 分析术后眼外肌肉扩张对IREOV的影响.
主要方法:
- 一项涉及69名患者 (124次轨道) 的回顾性研究,这些患者接受了MWD或LWD与TAO的脂肪减压.
- 利用人工智能轨道网系统进行轨道细分和IREOV计算.
- 评估术后眼外肌肉扩张的影响,将患者分为肌肉缩和脂肪增生组.
主要成果:
- 平均 IREOV 是 0.14 ± 0.08.08 的. 术后IREOV在MWD (0.17 ± 0.07) 之后明显高于LWD (0.05 ± 0.05) (P<0.001) 之后.
- 中间直肠肌肉扩张显著影响了MWD后的IREOV,而横向直肠肌肉扩张影响了LWD后的IREOV.
- 肌肉缩的TAO患者在MWD后的IREOV比脂肪缩患者高 (P<0.001). 在MWD和LWD (P>0.05) 之间,促进性减少是相似的.
结论:
- 通过人工智能准确计算IREOV对于评估轨道减压效率至关重要.
- 对于患有脂肪增生症的TAO患者,建议使用LWD来最大限度地降低眼外肌肉扩张的风险.
- 当MWD在患有脂肪增生症的患者身上进行时,对外眼肌肉扩张的术后监测至关重要.
相关概念视频
Assessment of the Rectum and Anus
2.1K
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
2.1K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
979
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
979
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
961
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
961


